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Abstract
Background: One of the basic prerequisites for generating evidence-based data is the availability
of classification systems. Attempts to date to classify breast cancer operations have focussed on
specific problems, e.g. the avoidance of secondary corrective surgery for surgical defects, rather
than taking a generic approach.
Methods: Starting from an existing, simpler empirical scheme based on the complexity of breast
surgical procedures, which was used in-house primarily in operative report-writing, a novel
classification of ablative and breast-conserving procedures initially needed to be developed and
elaborated systematically. To obtain proof of principle, a prospectively planned analysis of patient
records for all major breast cancer-related operations performed at our breast centre in 2005 and
2006 was conducted using the new classification. Data were analysed using basic descriptive
statistics such as frequency tables.
Results:  A novel two-type, six-tier classification system comprising 12 main categories, 13
subcategories and 39 sub-subcategories of oncological, oncoplastic and reconstructive breast
cancer-related surgery was successfully developed. Our system permitted unequivocal
classification, without exception, of all 1225 procedures performed in 1166 breast cancer patients
in 2005 and 2006.
Conclusion: Breast cancer-related surgical procedures can be generically classified according to
their surgical complexity. Analysis of all major procedures performed at our breast centre during
the study period provides proof of principle for this novel classification system. We envisage
various applications for this classification, including uses in randomised clinical trials, guideline
development, specialist surgical training, continuing professional development as well as quality of
care and public health research.
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Background
The treatment of breast cancer is multimodal and gener-
ally involves surgery, radiation and neoadjuvant and/or
adjuvant systemic therapy. Even today, these three basic
approaches to breast cancer therapy differ considerably
with regard to the availability of evidence-based medical
data required to evaluate the effectiveness and quality of
treatment [1,2]. Whereas systemic treatment of breast can-
cer and other malignancies has had a long tradition of
clinical trials [3-5], generating a large body of data with
high levels of evidence as defined by the Centre for Evi-
dence-Based Medicine, Oxford, UK [6,7], the amount of
evidence-based data available on radiation therapy is
more limited [8,9]. As regards breast cancer surgery, evi-
dence-based data are available practically only from stud-
ies comparing lumpectomy or quadrantectomy versus
mastectomy, or, in more abstract terms, breast-conserving
surgery (BCS) versus ablative breast surgery (ABS) [10-
12].
Currently, systematically generated data are lacking for
oncological (as opposed to plastic) breast surgery as well
as for what has come to be known as "oncoplastic" sur-
gery, i.e. surgery that combines both oncological and plas-
tic surgery procedures in a single operation. Hence, it has
not been possible to achieve for breast cancer surgery, par-
ticularly oncoplastic surgery, the high levels of evidence
demanded by the advocates of quality-assured treatment
and others [13-15]. In our opinion, this lack of evidence-
based data in breast cancer surgery largely results from the
absence of standardisation and classification of the vast
number of different surgical procedures and techniques in
use. We consider this to be especially true in the case of
oncoplastic breast surgery [14,16,17].
So far, oncoplastic procedures have only been classed
post-hoc with a view to anticipating future iatrogenic
defects in order to obviate the need for their repair and
minimise the cost and effort this involves [18,19]. To our
knowledge, no classification of breast cancer surgical pro-
cedures has yet been devised, or published, on the basis of
purely surgical criteria. However, such a classification sys-
tem is needed if data are to be generated that will enable
us to introduce the principles of evidence-based medicine
into breast cancer surgery and assess our surgical methods
in clinical trials to achieve high levels of evidence.
In the present paper, we propose the first comprehensive
classification system capable of accommodating, on the
basis of surgical complexity, any major oncological, onco-
plastic or reconstructive procedure used in the surgical
treatment of primary and locally recurrent breast cancer.
As a proof of principle, we have reviewed the operative
reports and hospital records of all female breast cancer
patients who underwent oncological, oncoplastic or
reconstructive surgical procedures in our department in
2005 and 2006, with the aim of assigning each operation
to one specific category within our classification system.
Methods
Study objective, design and setting
The main objectives of our study were twofold: (1) to
elaborate and refine an empirical scheme developed in-
house for classifying major oncological, oncoplastic and
reconstructive surgical procedures commonly performed
in breast cancer surgery; and (2) to demonstrate the gen-
eral applicability of our novel classification to all breast
cancer procedures by carrying out a proof-of-principle
analysis of all major breast cancer operations performed
at the Tübingen University Breast Centre in 2005 and
2006.
This study was designed as a prospective analysis of exist-
ing hospital treatment records. It was noninterventional,
and no patient-identifiable data were used in the analysis.
According to the relevant German laws and regulations,
the study therefore did not require approval by an inde-
pendent ethics committee or institutional review board,
or informed patient consent. This was confirmed in writ-
ing by the Ethics Committee of the Medical Faculty of the
University of Tübingen.
All breast surgical procedures were performed for the
treatment of any stage of breast cancer at the Department
of Obstetrics and Gynaecology, University of Tübingen
during the study period from 1 January 2005 to 31
December 2006.
Definitions
Oncoplastic surgery
Whereas "oncological surgery" and "reconstructive sur-
gery" are well-established terms requiring no further defi-
nition in the present context, "oncoplastic surgery" is a
relatively new concept for which there is no established,
generally accepted definition [20]. For the purposes of our
classification studies, we used the term "oncoplastic sur-
gery" to refer to any surgical procedure in which the pri-
mary surgical treatment strategy involved plastic surgical
techniques for partial or complete reconstruction of the
breast or for correction of surgical defects to the thoracic
wall. This definition was based on the concept of
"tumour-specific immediate reconstruction" (TSIR) pro-
posed by Audretsch et al. [21] and Bostwick and collabo-
rators [22]. In a broader sense, the terms "oncoplastic
surgery" and TSIR both also encompass the extension of
breast-conserving surgery to include the concomitant
application of plastic surgical techniques, immediate
reconstruction in the context of skin-sparing or modifiedBMC Cancer 2009, 9:108 http://www.biomedcentral.com/1471-2407/9/108
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radical mastectomies and thoracic wall reconstruction
after radical local surgery. Ultimately, both terms include
all procedures that are used to avoid defects or integrate
defect correction into the primary oncological procedure
and that are performed under the same oncological safety
criteria as the conventional surgical procedures.
Major surgical procedure
This term was used to describe any immediate or delayed
operation that involved a change of classification cate-
gory, e.g. conversion from a breast-conserving procedure
to mastectomy or from mastectomy to defect repair with
flap techniques in local radical excision. Secondary oper-
ations such as re-excision of breast tissue due to involved
margins were not considered major procedures provided
they did not require reclassification.
Complexity
This was used to refer to the technical difficulty of surgical
procedures.
Classification system
An initially simpler scheme used in-house to class breast
cancer-related operations was originally developed in our
department as a means of facilitating administrative tasks,
especially the efficient and systematic preparation of oper-
ative reports. This rudimentary system was considered a
suitable starting point for a comprehensive, systematic
classification system based on the surgical complexity of
breast cancer procedures.
Patients
Inclusion criteria
All women who underwent surgery for breast cancer at the
Breast Centre of the University of Tübingen during the
period from 1 January 2005 to 31 December 2006 were
eligible for inclusion in the study.
Exclusion criteria
There were no exclusion criteria. All female breast cancer
patients receiving major oncological, oncoplastic or
reconstructive surgery at the Breast Centre of the Univer-
sity of Tübingen during the study period were to be
included in the analysis.
Data analysis
Patient data
Patients' operative reports were reviewed by the investiga-
tors with regard to type of surgical procedure or proce-
dures performed and the extent and complexity of
surgery. Surgical procedures were assigned to one of sub-
subcategories, subcategories or main categories of the pro-
posed surgical classification system. Any procedure that
could not be unequivocally assigned to a category was to
be considered nonclassifiable.
Statistical methods
Due to the nature of the study, statistical analysis was lim-
ited to basic descriptive methods. Essentially, frequency
tables were generated and percentages calculated using
Microsoft Excel® 2002 (Microsoft Corporation, Redmond,
WA, USA).
Results
The novel classification system
The pre-existing rudimentary classification used in our
breast centre to facilitate administrative tasks such as pre-
paring operative reports was successfully expanded,
refined and placed on a systematic basis that reflected the
complexity of the procedures. A schematic representation
of the resulting novel, complexity-based systematic classi-
fication system of breast cancer-related surgical proce-
dures is given in Figure 1, which shows the two-type, six-
tier basic structure of the classification. A complete and
detailed listing of the 12 main categories and all sub- and
sub-subcategories with their definitions is given in Table
1.
Patients and operations
In total, 1166 women with breast cancer underwent 1225
major oncological, oncoplastic or reconstructive surgical
procedures at our Breast Centre between 1 January 2005
and 31 December 2006. All patients and procedures were
included in the present analysis.
Proof-of-principle analysis
The results of the analysis based on our classification sys-
tem are summarised in Table 2. Most importantly, our
novel classification system successfully accommodated all
1225 major breast cancer procedures performed at our
Breast Centre during the two-year study period, leaving no
unclassifiable procedures.
As a secondary result of our proof-of-principle analysis,
we obtained a remarkably detailed complexity profile of
the breast cancer-related surgery performed at our Breast
Centre during the study period (Table 2). Inspection of
the main-category data alone already gives a reasonably
accurate picture of the breast cancer surgery performed,
showing that 45% (552) of all 1225 major procedures
were ablative (ABS) and 55% (673) were breast-conserv-
ing (BCS) operations. More specifically, about 19% (of
1225 procedures) were simple ablative (Category A.1, see
Table 1) and about 15% were oncoplastic ablative proce-
dures (Categories A.3.a+b; A.4; A.5.a.1+2; A.5.b.1+2;
A.5.c.1+2; A.6.1+2), thus accounting for the vast majority
of ablative procedures. As regards breast-conserving sur-
gery, complex BCS (Category B.2; 15%), oncoplastic BCS
(B.3; 17%), complex oncoplastic BCS (B.4; 12%) and
complex oncoplastic BCS with additional resection of
mammary gland tissue (B.5; 10%) accounted for all butBMC Cancer 2009, 9:108 http://www.biomedcentral.com/1471-2407/9/108
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10 BCS procedures performed at the Tübingen University
Breast Centre in 2005 and 2006.
Discussion
Classification system
The complexity-based classification of breast surgical pro-
cedures we propose here is, to the best of our knowledge,
the first of its kind. No other generally applicable system
for the classification of breast cancer-related surgery
appears to have been published in the literature. Classifi-
cations developed to date have been based on post-thera-
peutic (i.e. after surgery and radiation treatment) analysis
of defects resulting from breast-conserving treatment and
the secondary repair surgery they entail [18,19]. Based on
such approaches, Munhoz and colleagues [23] very
recently published a classification system of breast-con-
Classification of ablative and breast-conserving surgical procedures for the treatment of breast cancer Figure 1
Classification of ablative and breast-conserving surgical procedures for the treatment of breast cancer. The sys-
tem is based on six levels of complexity of oncological, oncoplastic and delayed reconstructive surgery (simplified representa-
tion).
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Table 1: Complexity-based classification of oncological, oncoplastic and delayed reconstructive procedures in ablative (A) and breast-
conserving (B) breast cancer-related surgery.
A. Ablative surgical procedures
1. Simple ablative breast cancer surgery
Modified radical mastectomy or excision of a local recurrence after ablation (without reconstruction)
2. Complex ablative breast cancer surgery
Radical mastectomy or excision of a local recurrence after ablation (with removal of pectoral muscles and without reconstruction)
3. Oncoplastic ablative surgical procedures for breast cancer treatment with prosthetic reconstruction, or reconstruction 
after ablation
a. Modified radical mastectomy with immediate prosthetic reconstruction
1. Modified radical mastectomy with immediate placement of a tissue expander
2. Modified radical mastectomy with immediate placement of a permanent implant
b. Skin-sparing mastectomy with immediate prosthetic reconstruction
1. Skin-sparing mastectomy (SSM) and immediate placement of an implant
2. Nipple-sparing mastectomy (NSM) and immediate placement of an implant
c. Delayed prosthetic reconstruction after mastectomy
1. Delayed reconstruction after mastectomy: placement of a tissue expander
2. Delayed reconstruction after mastectomy: placement of a permanent implant
d. Implant-related procedures after implant reconstruction
1. Tissue expander removal and placement of a permanent implant
2. Implant exchange and breast remodelling in capsular contracture
4. Complex oncoplastic ablative breast cancer surgery involving defect repair with local flaps or free skin grafts 
(also in extensive chest wall recurrence)
1. Transposition flaps (e.g. the thoracoepigastric flap)
2. Rotation flaps
3. Local advancement flaps
4. Free skin transplants (e.g. a mesh graft)
5. Complex oncoplastic ablative breast cancer surgery with reconstruction or defect repair using distant pedicled flaps 
(also in extensive chest wall recurrence)
a. Conventional latissimus dorsi (LD) flaps (surgical or endoscopic harvest)
1. Conventional LD flap without or with an implant for immediate breast reconstruction as part of ablative surgery 
(modified radical mastectomy, SSM, NSM)
2. Conventional LD flap (usually without an implant) for repair of chest wall defects
3. Conventional LD flap without or with an implant for delayed breast reconstruction after ablative surgery
4. Conventional LD flap without or with an implant for autologous reconstruction or combined autologous and alloplastic reconstruction in prosthesis-
related complications
b. Extended latissimus dorsi (LD) flaps
1. Extended LD flap for immediate breast reconstruction as part of ablative surgery (modified radical mastectomy, SSM, NSM)
2. Extended LD flap for repair of chest wall defects
3. Extended LD flap for delayed breast reconstruction after ablative surgery
4. Extended LD flap for conversion to autologous reconstruction in prosthesis-related complications
c. Transverse rectus abdominis (TRAM) flaps
1. TRAM flap for immediate breast reconstruction as part of ablative surgery (modified radical mastectomy, SSM, NSM)
2. TRAM flap for repair of chest wall defects
3. TRAM flap for delayed breast reconstruction after ablative surgery
4. TRAM flap for conversion to autologous reconstruction in prosthesis-related complications
6. Complex oncoplastic ablative breast cancer surgery involving reconstruction or defect repair using free flaps with 
microvascular anastomosis (e.g. DIEP, SIEA, SGAP or free TRAM flaps) (also in extensive chest wall recurrence)
1. Free flap for immediate breast reconstruction as part of ablative surgery (modified radical mastectomy, SSM, NSM)
2. Free flap for repair of chest wall defects
3. Free flap for delayed breast reconstruction after ablative surgery
4. Free flap for conversion to autologous reconstruction in prosthesis-related complicationsBMC Cancer 2009, 9:108 http://www.biomedcentral.com/1471-2407/9/108
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serving surgery-related defects which facilitates the pro-
spective identification of individual, patient-specific
surgical solutions by using an algorithm for selecting the
appropriate surgical technique. However, all of these
approaches are limited to the specific purpose for which
they were developed and are not suitable for a wider range
of more general applications, e.g. randomised controlled
trials (RCTs) to generate evidence-based breast surgery
data, which are currently still lacking [20,24].
The selection of an appropriate, oncologically safe surgi-
cal procedure depends on numerous factors relating to,
inter alia, the individual patient, tumour characteristics
and surgeon's skills. In practice, it is not unusual that eval-
uation of a patient will result in her being offered several
surgical treatment options, frequently of different com-
plexity. We decided to base our classification on technical
sophistication and complexity of surgical procedures
because this principle of classification is independent of
B. Breast-conserving surgical procedures
1. Simple breast-conserving cancer surgery
(histologically complete tumour excision, performed as a "wide excision" up to quadrantectomy with defect repair involving only direct 
apposition without mobilisation of glandular tissue or skin flaps)
2. Complex breast-conserving cancer surgery
(additional intramammary reconstruction of the mammary gland by mobilisation of subcutaneous or epifascial glandular lobes and, if 
necessary, mobilisation of the skin envelope for defect repair of ≤ 25% of the area of the breast)
3. Oncoplastic breast-conserving surgery
(additional intramammary reconstruction of the mammary gland by mobilisation of subcutaneous or epifascial glandular lobes and, if 
necessary, mobilisation of the skin envelope for defect repair of > 25% of the area of the breast)
4. Complex oncoplastic breast-conserving surgery
a. Tumour-adapted mastopexy (breast lift) without additional removal of healthy breast tissue
(selection of skin incision pattern depending on amount of excess skin and desired scar pattern, i.e. purely circumareolar, vertical, 
segmental or "inverted T")
1. Central pedicles
2. Inferior-central pedicles
3. Cranial pedicles
4. Modified B mammoplasty
5. Free nipple transfer
b. Tumour resection with defect repair using local flaps without or with skin replacement
1. Transposition flaps (e.g. the thoracoepigastric flap)
2. Rotation flaps
5. Complex oncoplastic breast-conserving surgery with additional resection (reduction) of mammary gland tissue – 
Tumour-adapted reduction mammoplasty
(selection of skin incision pattern depending on amount of excess skin and desired scar pattern, i.e. purely circumareolar, vertical, 
segmental or "inverted T")
1. Central pedicles
2. Inferior-central pedicles
3. Cranial pedicles
4. Free nipple transfer
6. Complex oncoplastic breast-conserving surgery involving defect repair using distant pedicled flaps
a. Tumour resection with partial volume replacement using an endoscopically harvested latissimus dorsi flap
b. Tumour and skin resection with partial volume and skin replacement using a latissimus dorsi flap with a skin island
c. Tumour and, if required, skin resection with partial volume replacement and, if indicated, skin replacement using a pedicled 
TRAM flap
d. Tumour excision and, if indicated, skin resection with partial volume replacement and, if indicated, skin replacement using free 
flaps with microvascular anastomosis (e.g. DIEP, SIEA or SGAP flaps)
Table 1: Complexity-based classification of oncological, oncoplastic and delayed reconstructive procedures in ablative (A) and breast-
conserving (B) breast cancer-related surgery. (Continued)BMC Cancer 2009, 9:108 http://www.biomedcentral.com/1471-2407/9/108
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complex factors such as the individual patients' treatment
needs or surgeons' preferences, thus rendering our system
more practical and suitable for the purposes of scientific
research.
We consider the advantages of our novel classification sys-
tem to be that it is clinically orientated, easy to apply and
sufficiently differentiated without being overloaded.
Based on our experience of 1225 major breast cancer pro-
cedures in 1166 patients, we are confident that the com-
plexity-based classification system we propose here is
sufficiently comprehensive to accommodate virtually any
breast cancer-related surgical procedure. Our classifica-
tion is not limited to the procedures we actually per-
formed but rather also accommodates other types of
procedures we have not yet performed ourselves or for
which we saw no compelling indication in any of our
patients.
Proof of principle
All 1225 major breast cancer-related surgical procedures
performed at the Tübingen University Breast Centre dur-
ing the 2005–2006 study period were assignable to exactly
one category within our complexity-based classification
system, thus providing proof of principle for this novel
approach.
Potential applications and outlook
We can envisage numerous potential applications for our
classification system in various settings. For instance, in
an everyday clinical setting, it can be used to produce
operative reports more systematically and efficiently. At
an institutional level, our classification offers breast cen-
tres a simple and practical means of obtaining a transpar-
ent profile and overview of the range of breast cancer
surgical procedures they offer by determining the frequen-
cies of operations of the various classification categories as
percentages of total caseload. The proof-of-principle anal-
ysis shown in Table 2 is an example of such a frequency
analysis. Over longer periods of time, such analyses could
identify and illustrate any changes and trends in a hospi-
tal's capabilities and the range of operations it offers. At
the level of the individual breast cancer surgeon, the clas-
sification may also lend itself to categorising oncological,
oncoplastic and reconstructive surgical skills. Conversely,
higher surgical training curricula and continuing profes-
sional development (CPD) programmes for breast cancer
surgeons could be based on the classification system we
propose.
Furthermore, at the supra-institutional level, our classifi-
cation could be used for inter-hospital comparisons or
even in the context of benchmarking systems to achieve
greater transparency as regards the current situation and
Table 2: Classification-based analysis of all 1225 major 
procedures in 1166 breast cancer patients in 2005 and 2006
ABS BCS
1 231 (18.9%*) 9 (0.7%*)
2 9 (0.7%) 186 (15.2%)
3 206 (16.8%) 202 (16.5%)
3.a 25 --
12 4 --
21 --
3.b 74 --
16 6 --
28 --
3.c 13 --
11 3 --
20 --
3.d 94 --
16 7 --
22 7 --
4 27 (2.2%) 152 (12.4%)
4.a -- 144
18 4 8
23 1 1
31 6 3
40 8 2
5 -- 0
4.b -- 8
1 -- 7
2 -- 1
5 75 (6.1%) 123 (10.0%)
5.a 2 --
10 1 4
22 8 5
30 2 1
40 3
5.b 71 --
16 0 --
20 --
37 --
44 --
5.c 2 --BMC Cancer 2009, 9:108 http://www.biomedcentral.com/1471-2407/9/108
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quality of care in the surgical management of breast can-
cer. Similar comparisons at the national and even interna-
tional levels are also conceivable.
Lastly, we believe that the novel classification system we
propose will make it easier to address scientific questions
and issues in areas such as quality of care and public
health, and may enable a more scientific approach to
breast cancer surgery as such. As a result, data generated
from such research could ultimately contribute to the
development of evidence-based guidelines for the surgical
treatment of breast cancer.
Conclusion
Breast cancer-related surgical procedures can be generi-
cally classified according to their surgical complexity.
Proof of principle for our novel classification system was
obtained by descriptive statistical analysis which demon-
strated that our classification enabled unequivocal repre-
sentation all 1225 major procedures performed in 1166
women with breast cancer at the Tübingen University
Breast Centre during the study period from 1 January
2005 to 31 December 2006. Our classification system is
simple and easily applicable, sufficiently comprehensive
and differentiated without being too detailed or intricate.
We therefore consider it to be a suitable tool for a number
of purposes in various areas, including randomised clini-
cal trials and evidence-based data generation, guideline
development, specialist surgical training, continuing pro-
fessional development, as well as quality of care and pub-
lic health research relating to breast cancer surgery.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
JH conceived of the original scheme from which the clas-
sification was developed, participated in the study design,
collected and analysed the data, drafted the manuscript
and finalised it. DW conceived of the proof-of-principle
study, participated in the elaboration of the classification
system, conceived of the range of its applications and
revised the manuscript. Both authors read and approved
the final manuscript.
Acknowledgements
We wish to acknowledge the patients whose data we analysed in this study, 
and our fellow surgeons and clinical staff at the Tübingen University Breast 
Centre.
References
1. Cady B, Falkenberry SS, Chung MA: The surgeon's role in out-
come in contemporary breast cancer.  Surg Oncol Clin N Am
2000, 9(1):119-132. viii
2. Peto R: Meta-analysis on local therapy. Oral presentation.
27th San Antonio Breast Cancer Symposium 2004.
3. Fisher B, Wolmark N: New concepts in the management of pri-
mary breast cancer.  Cancer 1975, 36(2):627-632.
4. Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L,
Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, et al.:
Combination chemotherapy as an adjuvant treatment in
operable breast cancer.  N Engl J Med 1976, 294(8):405-410.
5. Cole BF, Gelber RD, Gelber S, Coates AS, Goldhirsch A: Polyche-
motherapy for early breast cancer: an overview of the ran-
domised clinical trials with quality-adjusted survival analysis.
Lancet 2001, 358(9278):277-286.
6. Oxford Centre for Evidence-based Medicine Levels of Evi-
dence (May 2001)   [http://www.cebm.net/index.aspx?o=1047]
7. Elstein AS: On the origins and development of evidence-based
medicine and medical decision making.  Inflamm Res 2004,
53(Suppl 2):S184-189.
8. Early Breast Cancer Trialists' Collaborative Group: Effects of radi-
otherapy and surgery in early breast cancer. An overview of
the randomized trials.  N Engl J Med 1995, 333(22):1444-1455.
9. Early Breast Cancer Trialists' Collaborative Group: Favourable and
unfavourable effects on long-term survival of radiotherapy
for early breast cancer: an overview of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group.  Lancet
2000, 355(9217):1757-1770.
10. van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong
D, Schueren E van der, Helle PA, van Zijl K, Bartelink H: Long-term
results of a randomized trial comparing breast-conserving
therapy with mastectomy: European Organization for
Research and Treatment of Cancer 10801 trial.  J Natl Cancer
Inst 2000, 92(14):1143-1150.
11. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER,
Jeong JH, Wolmark N: Twenty-year follow-up of a randomized
trial comparing total mastectomy, lumpectomy, and
lumpectomy plus irradiation for the treatment of invasive
breast cancer.  N Engl J Med 2002, 347(16):1233-1241.
12. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A,
Aguilar M, Marubini E: Twenty-year follow-up of a randomized
study comparing breast-conserving surgery with radical
mastectomy for early breast cancer.  N Engl J Med 2002,
347(16):1227-1232.
13. Rutgers EJ: Quality control in the locoregional treatment of
breast cancer.  Eur J Cancer 2001, 37(4):447-453.
14. Rew DA: Towards a scientific basis for oncoplastic breast sur-
gery.  Eur J Surg Oncol 2003, 29(2):105-106.
15. Birido N, Geraghty JG: Quality control in breast cancer surgery.
Eur J Surg Oncol 2005, 31(6):577-586.
10 --
20 --
31 --
41 --
6 4 (0.3%) 1 (0.0%)
6.a -- 1
11 --
20 --
31 --
42 --
6.b -- 0
6.c -- 0
6.d -- 0
Total of main categories 1–6 552 (45.1%) 673 (54.9%)
All patients underwent ablative breast surgery (ABS) or breast-conserving surgery 
(BCS) at the Breast Centre, Department of Obstetrics and Gynaecology, Tübingen 
University Hospital.
* % of 1225 procedures
-- nonexistent category
Table 2: Classification-based analysis of all 1225 major 
procedures in 1166 breast cancer patients in 2005 and 2006 Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cancer 2009, 9:108 http://www.biomedcentral.com/1471-2407/9/108
Page 9 of 9
(page number not for citation purposes)
16. Benson JR, Querci della Rovere G: Towards a scientific basis for
oncoplastic breast surgery.  Eur J Surg Oncol 2003, 29(7):629.
17. Asgeirsson KS, Rasheed T, McCulley SJ, Macmillan RD: Oncological
and cosmetic outcomes of oncoplastic breast conserving sur-
gery.  Eur J Surg Oncol 2005, 31(8):817-823.
18. Clough KB, Cuminet J, Fitoussi A, Nos C, Mosseri V: Cosmetic
sequelae after conservative treatment for breast cancer:
classification and results of surgical correction.  Ann Plast Surg
1998, 41(5):471-481.
19. Clough KB, Thomas SS, Fitoussi AD, Couturaud B, Reyal F, Falcou
MC: Reconstruction after conservative treatment for breast
cancer: cosmetic sequelae classification revisited.  Plast Recon-
str Surg 2004, 114(7):1743-1753.
20. Rutgers EJ: Guidelines to assure quality in breast cancer sur-
gery.  Eur J Surg Oncol 2005, 31(6):568-576.
21. Audretsch W, Rezai M, Kolotas C, Zamboglou N, Schnabel T, Bojar
H:  Tumor-specific immediate reconstruction (TSIR) in
breast cancer patients.  Perspect Plast Surg 1998, 11:71-106.
22. Losken A, Elwood ET, Styblo TM, Bostwick J 3rd: The role of
reduction mammaplasty in reconstructing partial mastec-
tomy defects.  Plast Reconstr Surg 2002, 109(3):968-975. discussion
976-967.
23. Munhoz AM, Montag E, Arruda E, Pellarin L, Filassi JR, Piato JR, de Bar-
ros AC, Prado LC, Fonseca A, Baracat E, et al.: Assessment of
immediate conservative breast surgery reconstruction: a
classification system of defects revisited and an algorithm for
selecting the appropriate technique.  Plast Reconstr Surg 2008,
121(3):716-727.
24. Baildam AD: Breast reconstruction – state of the art.  Breast
2006, 15(Suppl 2):S27-30.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2407/9/108/pre
pub